Bio-Techne Corporation
IT ˙ BIT ˙ US09073M1045
54,00 € 0,00 (0,00%)
2026-06-03
AKTIENPREIS
SecurityIT:1TECH / Bio-Techne Corporation
InstitutionMorgan Stanley
Latest Disclosed Ownership995,735 shares
Ownership 2.70%
Morgan Stanley ownership in 1TECH / Bio-Techne Corporation

2013-04-08 - Morgan Stanley has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 995,735 shares of Bio-Techne Corporation (IT:1TECH). This represents 2.7 percent ownership of the company.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2013-04-08 2013-04-08 13G/A 995,735 2.70
2013-02-13 2013-02-13 13G/A 3,135,761 8.50
2012-03-08 2012-03-08 13G/A 3,718,050 10.10
2012-02-08 2012-02-08 13G/A 3,643,788 9.80

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BIO-TECHNE COM 09073M104 8,532,873 187,459 2.25 445,928 -9.14 0.0269
2026-05-27 2025-12-31 13F/A-1 BIO-TECHNE COM 09073M104 8,345,414 1,107,536 15.30 490,794 21.89 0.0293
2026-02-13 2025-12-31 13F BIO-TECHNE COM 09073M104 8,345,414 1,107,536 490,794 0.0293
2026-05-27 2025-09-30 13F/A-1 BIO-TECHNE COM 09073M104 7,237,878 658,935 10.02 402,643 18.95 0.0244
2025-11-14 2025-09-30 13F BIO-TECHNE COM 09073M104 7,237,878 658,935 402,643 0.0244
2025-08-15 2025-06-30 13F BIO-TECHNE COM 09073M104 6,578,943 859,403 15.03 338,487 0.94 0.0221
2025-05-15 2025-03-31 13F BIO-TECHNE COM 09073M104 5,719,540 961,015 20.20 335,337 -2.16 0.0240
2025-05-15 2024-12-31 13F/A-1 BIO-TECHNE COM 09073M104 4,758,525 100,934 2.17 342,757 -7.93 0.0240
2025-02-14 2024-12-31 13F BIO-TECHNE COM 09073M104 4,758,525 100,934 342,757 0.0240
2025-05-14 2024-09-30 13F/A-2 BIO-TECHNE COM 09073M104 4,657,591 246,895 5.60 372,281 17.80 0.0270
2025-02-14 2024-09-30 13F/A-1 BIO-TECHNE COM 09073M104 4,657,591 246,895 372,281 0.0270
2024-11-14 2024-09-30 13F BIO-TECHNE COM 09073M104 4,657,591 246,895 372,281 0.0270
2025-05-14 2024-06-30 13F/A-2 BIO-TECHNE COM 09073M104 4,410,696 220,418 5.26 316,027 7.14 0.0245
2024-10-17 2024-06-30 13F/A-1 BIO-TECHNE COM 09073M104 4,410,696 220,418 316,027 0.0245
2024-08-14 2024-06-30 13F BIO-TECHNE COM 09073M104 4,410,696 220,418 316,027 0.0245
2024-10-17 2024-03-31 13F/A-2 BIO-TECHNE COM 09073M104 4,190,278 102,183 2.50 294,954 -6.49 0.0237
2024-08-16 2024-03-31 13F/A-1 BIO-TECHNE COM 09073M104 4,190,278 102,183 294,954 0.0028
2024-05-15 2024-03-31 13F BIO-TECHNE COM 09073M104 4,190,278 102,183 294,954 0.0237
2024-08-16 2023-12-31 13F/A-1 BIO-TECHNE COM 09073M104 4,088,095 782,269 23.66 315,438 40.18 0.0278
2024-02-13 2023-12-31 13F BIO-TECHNE COM 09073M104 4,088,095 782,269 315,438 0.0278
2023-11-15 2023-09-30 13F BIO-TECHNE COM 09073M104 3,305,826 143,716 4.54 225,028 -12.82 0.0229
2023-08-14 2023-06-30 13F BIO-TECHNE COM 09073M104 3,162,110 -22,072 -0.69 258,123 9.27 0.0254
2023-05-15 2023-03-31 13F BIO-TECHNE COM 09073M104 3,184,182 201,552 6.76 236,235 -4.44 0.0253
2023-02-14 2022-12-31 13F BIO-TECHNE COM 09073M104 2,982,630 2,769,642 1,300.37 247,200 308.67 0.0281
2022-11-14 2022-09-30 13F BIO-TECHNE COM 09073M104 212,988 -17,616 -7.64 60,489 -24.33 0.0082
2022-10-27 2022-06-30 13F/A-1 BIO-TECHNE COM 09073M104 230,604 124,828 118.01 79,937 74.50 0.0104
2022-08-15 2022-06-30 13F BIO-TECHNE COM 09073M104 230,604 124,828 79,937 0.0104
2022-10-27 2022-03-31 13F/A-1 BIO-TECHNE COM 09073M104 105,776 10,611 11.15 45,808 -6.96 0.0062
2022-05-13 2022-03-31 13F BIO-TECHNE COM 09073M104 105,776 10,611 45,808 0.0062
2022-02-14 2021-12-31 13F BIO-TECHNE COM 09073M104 95,165 -20,306 -17.59 49,234 -12.01 0.0061
2021-11-15 2021-09-30 13F BIO-TECHNE COM 09073M104 115,471 33,662 41.15 55,954 51.90 0.0075
2021-08-23 2021-06-30 13F/A-1 BIO-TECHNE COM 09073M104 81,809 42,097 106.01 36,835 142.83 0.0049
2021-08-16 2021-06-30 13F BIO-TECHNE COM 09073M104 81,809 42,097 36,835 0.0010
2021-05-17 2021-03-31 13F BIO-TECHNE COM 09073M104 39,712 -37,720 -48.71 15,169 -38.31 0.0022
2021-02-16 2020-12-31 13F BIO-TECHNE COM 09073M104 77,432 43,879 130.78 24,588 195.85 0.0038
2020-11-13 2020-09-30 13F BIO-TECHNE COM 09073M104 33,553 -2,003 -5.63 8,311 -11.47 0.0016
2020-08-14 2020-06-30 13F BIO-TECHNE COM 09073M104 35,556 -71,613 -66.82 9,388 -53.80 0.0021
2020-05-26 2020-03-31 13F/A-1 BIO-TECHNE COM 09073M104 107,169 51,351 92.00 20,321 65.85 0.0055
2020-05-15 2020-03-31 13F BIO-TECHNE COM 09073M104 107,169 51,351 20,321 1,561.0764
2020-02-14 2019-12-31 13F BIO TECHNE COM 09073M104 55,818 21,583 63.04 12,253 82.91 0.0028
2019-11-14 2019-09-30 13F BIO TECHNE COM 09073M104 34,235 -9,874 -22.39 6,699 -27.15 0.0018
2019-08-14 2019-06-30 13F BIO TECHNE COM 09073M104 44,109 -13,871 -23.92 9,196 -20.11 0.0024
2019-05-15 2019-03-31 13F BIO TECHNE COM 09073M104 57,980 21,066 57.07 11,511 115.48 0.0033
2019-02-14 2018-12-31 13F BIO TECHNE COM 09073M104 36,914 -46,539 -55.77 5,342 -68.64 0.0016
2019-04-23 2018-09-30 13F/A-2 BIO TECHNE COM 09073M104 83,453 -41,742 -33.34 17,034 -8.03 0.0043
2018-11-20 2018-09-30 13F/A-1 BIO TECHNE COM 09073M104 83,453 0 17,034 0.0043
2018-11-14 2018-09-30 13F BIO TECHNE COM 09073M104 83,453 -41,742 17,034
2019-04-23 2018-06-30 13F/A-1 BIO TECHNE COM 09073M104 125,195 34,420 37.92 18,522 35.08 0.0050
2018-08-14 2018-06-30 13F BIO TECHNE COM 09073M104 125,195 34,420 18,522
2019-04-23 2018-03-31 13F/A-1 BIO TECHNE COM 09073M104 90,775 -23,570 -20.61 13,712 -7.43 0.0038
2018-05-14 2018-03-31 13F BIO TECHNE COM 09073M104 90,775 -23,570 13,712
2019-04-23 2017-12-31 13F/A-1 BIO TECHNE COM 09073M104 114,345 10,522 10.13 14,813 18.01 0.0041
2018-02-14 2017-12-31 13F BIO TECHNE COM 09073M104 114,345 10,522 14,813
2017-11-14 2017-09-30 13F BIO TECHNE COM 09073M104 103,823 37,459 56.44 12,552 60.96 0.0038
2017-08-11 2017-06-30 13F BIO TECHNE COM 09073M104 66,364 -23,762 -26.37 7,798 -14.89 0.0024
2017-05-22 2017-03-31 13F/A-1 BIO TECHNE COM 09073M104 90,126 4,988 5.86 9,162 4.66 0.0028
2017-05-12 2017-03-31 13F BIO TECHNE COM 09073M104 90,126 9,162
2017-02-22 2016-12-31 13F/A-1 BIO TECHNE COM 09073M104 85,138 39,274 85.63 8,754 74.28 0.0029
2017-02-13 2016-12-31 13F BIO TECHNE COM 09073M104 85,138 8,754
2016-11-10 2016-09-30 13F BIO TECHNE COM 09073M104 45,864 -7,756 -14.46 5,023 -16.93 0.0017
2016-08-12 2016-06-30 13F BIO TECHNE COM 09073M104 53,620 22,782 73.88 6,047 107.44 0.0022
2016-05-12 2016-03-31 13F BIO TECHNE COM 09073M104 30,838 874 2.92 2,915 8.08 0.0011
2016-02-09 2015-12-31 13F BIO TECHNE COM 09073M104 29,964 -25,631 -46.10 2,697 -47.53 0.0010
2016-02-08 2015-09-30 13F/A-1 BIO TECHNE COM 09073M104 55,595 -17,090 -23.51 5,140 -28.19 0.0019
2015-11-09 2015-09-30 13F BIO TECHNE COM 09073M104 55,595 5,140
2015-08-12 2015-06-30 13F BIO TECHNE COM 09073M104 72,685 7,202 11.00 7,158 9.00 0.0025
2015-05-14 2015-03-31 13F BIO TECHNE COM 09073M104 65,483 -6,007 -8.40 6,567 -0.61 0.0024
2015-02-13 2014-12-31 13F BIO TECHNE COM 09073M104 71,490 -13,311 -15.70 6,607 -16.71 0.0024
2014-12-16 2014-09-30 13F/A-1 TECHNE COM 878377100 84,801 42,078 98.49 7,933 117.52 0.0031
2014-11-14 2014-09-30 13F TECHNE COM 878377100 84,801 7,933
2014-05-13 2014-03-31 13F TECHNE COM 878377100 42,723 -369,104 -89.63 3,647 -90.65 0.0015
2014-02-13 2013-12-31 13F TECHNE COM 878377100 411,827 -300,828 -42.21 38,988 -31.67 0.0166
2013-11-13 2013-09-30 13F TECHNE CORP COM ST COM 878377100 712,655 52,548 7.96 57,056 25.13 0.0270
2013-08-08 2013-06-30 13F TECHNE CORP COM ST COM 878377100 660,107 660,107 45,599 0.0230
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.